
Content protection and maximized extraction
Surface treatment of pharmaceutical glass packaging is an established method of protection for most parenteral content and certain APIs and excipients that may interact with the glass surface. While the hydrolytic resistance of Type I Borosilicate glass makes it a suitable containment solution for most applications, some liquids when in contact with an untreated glass surface pose a risk of glass delamination, excessive surface adhesion, and fogging.
DWK’s siliconization formulation has been carefully engineered to bond a REACH compliant Dimethicone to the glass surface. Resulting in siliconized vials designed to protect sensitive biologics, maximize extraction of viscous and protein-based content, and the ability to reduce content adherence to the glass surface. The resulting hydrophobic surface can also improve the formation of lyophilization cakes and elastomer closure insertion force.
Siliconized glass is validated, whiteroom packed in coroplast trays and shrink wrapped for shipment with lot traceability documentation. In addition to siliconization, DWK offers silanization and other surface treatments. Rely on DWK to help you select a surface treatment most appropriate for your drug content, storage conditions, shelf life, and sterilization process.